Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
Abstract The dichotomic nature of the adaptive immune response governs the outcome of clinical gene therapy. On the one hand, neutralizing antibodies and cytotoxic T cells can have a dramatic impact on the efficacy and safety of human gene therapies. On the other hand, regulatory T cells (Treg) can...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Revisão |
| 言語: | 英語 |
| 出版事項: |
2021
|
| オンライン･アクセス: | https://doi.org/10.1038/s41434-021-00232-2 https://www.nature.com/articles/s41434-021-00232-2.pdf |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|